SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-012659
Filing Date
2016-02-03
Accepted
2016-02-03 21:46:07
Documents
1
Period of Report
2016-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3387
  Complete submission text file 0000899243-16-012659.txt   4765
Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address
Schembri John (Reporting) CIK: 0001375857 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 161386666

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations